Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea

NCT03729271 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
148
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Michigan

Collaborators